Generative AI (GenAI) is set to hyper-personalise care services, as 49.6% of healthcare providers plan to invest in GenAI use cases.
The IDC report, AI in Healthcare: Redefining Explainability in the Context of Generative AI reveals the current landscape and investment trend by the Asia/Pacific healthcare organisations on Generative AI.
The report highlights the prominent use cases and potential impact of leveraging GenAI tools in the healthcare sector, both to augment clinician efficiency and redefine patient experiences.
The report also emphasises the necessity for “explainability” in the context of Generative AI use case adoptions in healthcare, as diagnosis and treatment plans by the AI-generated tools have significant impacts on patients’ lives.
Report highlights
- Half of the healthcare providers in Asia/Pacific plan to invest in Generative AI technologies.
- Marketing, Knowledge Management and Conversational applications are the top Generative AI use cases for Asia/Pacific healthcare organisations moving forward, according to IDC Future Enterprise Resiliency and Spending (FERS) survey data.
- Healthcare organisations in the region are cognizant of the need for ethical aspects. According to FERS survey, while 61% of the healthcare organisations in the region are in the process of adopting data ethics requirements, 14% adhere to ethical aspects of data already in their organisations.
“Generative AI use cases are being adopted across industries. In healthcare, Gen AI has immense potential in addressing inherent challenges to increase productivity, attain hyper-personalisation and enhance physician/patient experience by leveraging capabilities of large language models (LLMs)," says Manoj Vallikkat, senior research manager, IDC Asia/Pacific Healthcare Insights.
"It is imperative that the healthcare organisations be compliant and ensure explainability while adopting such new wave AI-tools," he continued.
